Growing children don’t have time to wait. Neither do you.
Over 700,000 U.S. children have harmful blood lead levels1,2. Have you found the children at risk in your practice?
Who should be tested?
Federal law requires that all Medicaid eligible children be tested at 12 and 24 months and ages 36 to 72 months if they have not previously been tested.
Each state has guidelines for blood lead testing. The American Academy of Pediatrics (AAP) recommends that “children should be tested at least once when they are 2 years of age or, ideally, twice, at 1 and 2 years of age, unless lead exposure can be confidently excluded.”4
Contact us for information to help you determine your state’s specific testing requirements.
Who is at risk for lead exposure? Children are considered at risk if any of the following are true4:
Child lives in or frequently visits a home built before 1950, or a recently renovated home built before 1978
Child has a sibling or frequent playmate with elevated blood lead levels
Child's parent or primary caregiver works with lead. Examples include: battery recycling or manufacture, lead smelting, lead mining, auto repair, shipbuilding, construction, plumbing, and glass manufacture5
Child is a recent immigrant, refugee, or foreign adoptee.
Child has a household member who uses traditional, folk, or ethnic remedies or cosmetics or who routinely eats food imported informally (e.g., by a family member)
No safe levels. Evidence continues to grow that blood lead levels as low as 5 ug/dL may impair cognition3, with no minimum threshold yet identified.
Lifelong consequences of lead exposure include:
Six times higher likelihood of having a reading disability6
Being seven times more likely to drop out of high school6
Lower scores on neurobehavioral development7
Lower scores on tests for math, reading, nonverbal reasoning and short term memory7
Hypertension that contributes to adult cardiovascular disease8
Decline in IQ with every 1.0 μg/dL increase in blood lead9
Early diagnosis helps to quickly address the effects of lead exposure and provides impetus for lead abatement in homes.
LeadCare II is the only CLIA-waived point-of-care blood lead testing system. Employees of an office or lab operating under a CLIA Certificate of Waiver can administer the test.
To request more information or to schedule a product demonstration, contact us.